Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SNTA > SEC Filings for SNTA > Form 8-K on 1-Dec-2011All Recent SEC Filings

Show all filings for SYNTA PHARMACEUTICALS CORP

Form 8-K for SYNTA PHARMACEUTICALS CORP


1-Dec-2011

Entry into a Material Definitive Agreement, Financial Statements and E


ITEM 1.01 Entry into a Material Definitive Agreement.

On August 4, 2011, Synta Pharmaceuticals Corp. (the "Company") filed a shelf registration statement on Form S-3 (File No. 333-176022), which was declared effective by the Securities and Exchange Commission on August 19, 2011 (the "Registration Statement"). In connection with the filing of the Registration Statement, the Company obtained waivers of the registration rights held by the parties to the Company's Amended and Restated Investor Rights Agreement, dated December 13, 2002, as amended (the "Investor Rights Agreement"). In consideration of these waivers, on November 30, 2011, the Company and the parties to the Investor Rights Agreement, including Keith Gollust and Bruce Kovner, directors of the Company, entered into the Third Amendment to the Investor Rights Agreement (the "Amendment"), pursuant to which the termination date of the registration rights provided for therein was extended from February 9, 2012 to February 9, 2015.

The foregoing is a summary description of the terms and conditions of the Amendment and is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.



ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
Number                                   Description

10.1        Third Amendment, dated November 30, 2011, to the Amended and Restated
            Investor Rights Agreement, dated December 13, 2002, as amended, by and
            among Synta Pharmaceuticals Corp. and certain stockholders of Synta
            Pharmaceuticals Corp.


  Add SNTA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SNTA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.